US and them

With the US pharmaceutical giants targeting the elusive UK market, the issue of whether drug companies should be able to advertise their wares direct to the public is more pertinent than ever. Caroline White reports

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here